Chlamydia pneumoniae in atheroma: Consideration of criteria for causality

Journal of Clinical Pathology

Volumn 51, Issue 11, 1998, Pages 812-817

  Shor, Allan ^a   Phillips, James I ^b   Ong, Gloria ^c   Thomas, Brenda J ^c   Taylor Robinson, David ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b National Centre for Occupational Health   (South Africa)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Chlamydia pneumoniae

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROMA; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0031741532     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.11.812     Document Type: Article

References (45)

1. Grayston JT, Kuo C-C, Wang SP, et al. A new Chlamydia psittaci strain, TWAR, isolated from acute respiratory tract infections. N Engl J Med 1986;315:161-8.
2. Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992;15:757-63.
3. Saikku P, Mattila K, Nieminen MS, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;ii:983-6.
4. Leinonen M, Linnanmaki E, Mattila K, et al. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog 1990;9: 67-73.
5. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992;116:273-8.
6. Linnanmaki E, Leinonen M, Mattila K, et al. Chlamydia pneumoniae specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 1993;87:1130-4.
7. Thom DH, Wang S-P, Grayston JT, et al. Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary heart disease. Arterioscler Thromb 1991; 11:547-51.
8. Thom DH, Grayston JT, Siscovick DS, et al. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72.
9. Patel P, Kendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease. BMJ 1995;311:711-14.
10. Melnick S, Shahar E, Folsom A, et al. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. JAMA 1993;95:199-504.
11. Jackson L, Grayston T. Chlamydia pneumoniae and Mycoplasma pneumoniae infections. Curr Opin Infect Dis 1996;9:89-93.
12. Shor A, Kuo C-C, Patton DL. Detection of Chlamydia pneumoniae in the coronary artery atheroma plaque. S Afr Med J 1992;82:158-61.
13. Kuo C-C, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.
14. Kuo C-C, Gown AM, Benditt EP, et al. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 1993; 13:1501-4.
15. Kuo C-C, Grayston JT, Campbell LA, et al. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-35 years old). Proc Natl Acad Sci USA 1995;92:6911-14.
16. Campbell LA, O'Brien ER, Cappuccio AL, et al. Detection of Chlamydia pneumoniae (TWAR) in human coronary artherectomy tissue. J Infect Dis 1995;172:585-8.
17. Ouchi K, Fujii B, Kamamoto Y, et al. Detection of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries and large arteries [abstract]. 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, 17-20 September 1995:294 (abstract K37).
18. Juvonen J, Juvonen T, Laurila A, et al. Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms [abstract]. Third International Congress on the Macrolides, Azalides and Streptogramins. Lisbon, 24-26 January 1996.
19. Ong G, Thomas BJ, Mansfield AO, et al. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996;49:102-6.
20. Grayston JT, Kuo C-C, Coulson AS, et al. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995;92:3397-400.
21. Kuo C-C, Coulson AS, Campbell LA, et al. Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg 1997;26:29-31.
22. Ramirez JA, the Chlamydia pneumoniae/Atherosclerosis Study Group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 1996;125:979-82.
23. Maas M, Krause E, Kruger S, et al. Coronary arteries harbour viable Chlamydia pneumoniae. Fourth international symposium on modern concepts in endocarditis and cardiovascular infections [abstract]. Yverdon-Les-Baines, Switzerland, May 1997 (abstract 101).
24. Jackson LA, Campbell LA, Kuo C-C, et al. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 1997;176:292-5.
25. Woolf N. Pathology of atherosclerosis. London: Butterworth, 1982.
26. Hill AB. The environment and disease, association or causation? Proc R Soc Med 1965;58:295-300.
27. Phillips JI, Isaacson C, Carman H. Ochronosis in black South Africans who used skin lighteners. Am J Dermatopathol 1986;8:14-21.
28. Phillips JI. Lack of cilia and squamous metaplasia in upper respiratory tract biopsies from children. S Afr Med J 1989; 76:355-7.
29. Nadji M. Immunoperoxidase techniques. Am J Dermatopathol 1986;8:32-6.
30. Wissler RW. Significance of Chlamydia pneumoniae (TWAR) in atherosclerotic lesions. Circulation 1995;92: 3376.
31. Weiss SM, Roblin PM, Gaydos CA, et al. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 1996;173:957-62.
32. Jackson LA, Campbell LA, Kuo C-C, et al. Detection of Chlamydia pneumoniae in atheroma specimens. J Infect Dis 1996;174:893-6.
33. Jackson LA, Campbell LA, Schmidt RA, et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma. Am J Pathol 1997;150:1785-90.
34. Knoebel E, Vijayagopal P, Figueroa JE, et al. In vitro infection of smooth muscle cells by Chlamydia pneumoniae. Infect Immun 1997;65:503-6.
35. Gaydos CA, Summersgill JT, Sahney NN, et al. Replication of Chlamydia pneumoniae in human macrophages, endothelial cells and aortic artery smooth muscle cells. Infect Immun 1996;64:1614-20.
36. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1993;362:801-9.
37. Hajjar DP, Nicholson AC. Atherosclerosis. Am Scientist 1995;83:460-7.
38. Blanchard T, Bailey R, Holland M, et al. Chlamydia pneumoniae and atherosclerosis. Lancet 1993;341:825.
39. Maseri A, Biasucci LM, Liuzzo G. Inflammation in ischaemic heart disease. BMJ 1996;312:1049-50.
40. Mendall MA, Patel P, Ballam L, et al. C-reactive protein and its relation to cardiovascular risk factors: a population-based cross-sectional study. BMJ 1996;312:1061-5.
41. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
42. Moazed TC, Kuo C-C, Grayston JT, et al. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 1997;175:883-90.
43. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998;97:633-6.
44. Gupta S, Leathan EW, Carrington D, et al. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
45. Gurfinkel E, Bozovich G, Daroca A, et al. and ROXIS study group. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: Roxis pilot study. Lancet 1997;350: 404-7.